Pretreatment with Interleukin-2 Modulates Perioperative Immunodysfunction in Patients with Renal Cell Carcinoma
Malte Böhm1, A. Ittenson2, T. Klatte1, K. F. Schierbaum1, F.-W. Röhl3, S. Ansorge2, E. P. Allhoff1
1Department of Urology, Otto-von-Guericke-University, Magdeburg, Germany 2Institute of Experimental Internal Medicine, Otto-von-Guericke-University, Magdeburg, Germany 3Institute of Biometrics and Medical Informatics, Otto-von-Guericke-University, Magdeburg, Germany
Received January 2003
Accepted February 2003
Crossref Cited-by Linking
Horowitz Maya, Neeman Elad, Sharon Eran, Ben-Eliyahu Shamgar: Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat Rev Clin Oncol2015, 12, 213. <https://doi.org/10.1038/nrclinonc.2014.224>
